copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Yellow fever - World Health Organization (WHO) Yellow fever is an epidemic-prone vector-borne vaccine preventable viral disease that is transmitted to humans by the bites of infected mosquitos In some of the unvaccinated individuals, the virus can cause severe illness including jaundice and bleeding (severe cases)
Vaccines and vaccination against yellow fever: WHO Position Paper . . . This updated position paper on yellow fever (YF) vaccines and vaccination replaces the previous 2003 WHO position paper and summarizes recent developments in the field Recommendations on the use of YF vaccines were last discussed by SAGE at its meeting in April 2013
Yellow Fever - World Health Organization (WHO) Public health aspects Yellow fever (YF) is a mosquito-borne, viral haemorrhagic fever that is endemic in tropical areas of Africa and South America, where is has caused outbreaks at irregular intervals for centuries Like plague and cholera, YF is subject to control measures outlined in the International health regulations WHO estimates that a total of 200 000 cases of YF occur each year
Yellow Fever - West and Central Africa Yellow fever (YF) is an acute viral disease transmitted by infected mosquitoes (including Aedes sp and Haemogogus sp) Transmission can be amplified in circumstances where the Aedes mosquitos (day feeder) are present in urban settings and densely populated areas causing a rapid spread of the disease While many people who become infected do not experience severe symptoms, a subset will
Eliminate Yellow Fever Epidemics (EYE) 2017–2026 Overview The global health community is facing an increased risk of urban outbreaks of yellow fever (YF) The risk of international spread, YF’s changing epidemiology and resurgence of mosquitoes pose an emerging global threat that requires new strategic thinking This document describes the reasoning behind and need for an updated, long-term (2017-2026) and global strategy to “Eliminate
Risk mapping - World Health Organization (WHO) The scarcity of well documented and consistent methods in YF risk assessment and the changing global epidemiology of the disease emphasised the need to revise classification and standardise the geographical risk assessment for YF For instance, in late 2007 and early 2008, the disease re-emerged in Paraguay and Argentina after more than 30 years Furthermore, increased numbers of cases were
Yellow fever vaccine: WHO position on the use of fractional doses . . . This updated position paper on yellow fever (YF) vaccines and vaccination replaces the previous 2003 WHO position paper and summarizes recent developments in the field Recommendations on the use of YF vaccines were last discussed by SAGE at its meeting in April 2013
Immunization, Vaccines and Biologicals The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy
Yellow fever - World Health Organization (WHO) The YF Initiative (YFI) led by WHO and UNICEF coordinates yellow fever control at the global level The goals of the Initiative are to prevent yellow fever outbreaks and to secure the supply of yellow fever vaccines